Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,392,632
-
Share change
-
+365,107
-
Total reported value
-
$608,333,577
-
Put/Call ratio
-
74%
-
Price per share
-
$48.99
-
Number of holders
-
89
-
Value change
-
+$13,343,069
-
Number of buys
-
40
-
Number of sells
-
54
Institutional Holders of EIDOS THERAPEUTICS INC - COM (EIDX) as of Q1 2020
As of 31 Mar 2020,
EIDOS THERAPEUTICS INC - COM (EIDX) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,392,632 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., Aisling Capital Management LP, Cormorant Asset Management, LP, Redmile Group, LLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, FMR LLC, GILDER GAGNON HOWE & CO LLC, and Artisan Partners Limited Partnership.
This page lists
89
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.